Schedule 13D ownership disclosure

Cartesian Therapeutics Inc

Security class unavailable · CUSIP: 816212302

Event date: 2024-09-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,841,756
Percent of class
36.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-082736
Form type
SC 13D/A
Filer
Cartesian Therapeutics, Inc.
CIK
CIK 1453687
Filed
Sep 27, 2024
Reporting period
Sep 25, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub